Characterization of the Overlap Syndrome of Primary Biliary Cirrhosis (Pbc) and Autoimmune Hepatitis: Evidence for It Being A Hepatitic Form of Pbc in Genetically Susceptible Individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Some patients with autoimmune liver disease present with a clinical and/or histological picture showing characteristic findings of both autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC). Various names, mostly overlap syndrome, have been used to describe these cases, which have thus far not been more closely characterized. The aim of this study was the comparison of 20 patients with overlapping features to representative patients considered suffering from typical AIH or typical PBC (20 patients in each group). We found these patients to indeed show a very mixed picture of both conditions biochemically, serologically, and histologically. However, closer analysis suggested that all of these patients were primarily suffering from PBC as all of them had at least either bile duct destruction on histology or anti–M2 positive antimitochondrial antibodies (AMA). We suggest that these PBC patients because of their genetic susceptibility, evidenced by the AIH–characteristic histocompatibility leukocyte antigen (HLA) type B8, DR3, or DR4, developed a more hepatitic picture. Response to immunosuppressive therapy was excellent. We propose that the name “overlap syndrome” be abandoned for “PBC, hepatitic form.” These observations not only have pathophysiological implications, but also suggest that therapy of PBC should be guided by the degree of biochemical and histological hepatic involvement
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This combined treatment regime has been used in patients with PBC and features of AIH with high response rates [160,161,175,180].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [180]
In the citing paper
“These criteria have been met in 1% to 14.2% of PBC patients, with higher rates found in Hispanic PBC patients.(128)(129)(130)(131)(132)(133)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [128]
Citations
Cites
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Bach, N., Thung, S. N., & Schaffner, F. (1992) · Hepatology · doi:10.1002/hep.1840150403 · Cited by 500
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Self-citationFrequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Michieletti, P., Wanless, I. R., Katz, A., Scheuer, P. J., Yeaman, S. J., Bassendine, M. F., Palmer, J. M., & Heathcote, E. J. (1994) · Gut · doi:10.1136/gut.35.2.260 · Cited by 236
Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
Ben-Ari, Z., Dhillon, A. P., & Sherlock, S. (1993) · Hepatology · doi:10.1002/hep.1840180103 · Cited by 218
Krawitt, E. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604043341406 · Cited by 206
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Goodman, Z. D., McNally, P. R., Davis, D. R., & Ishak, K. G. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065530 · Cited by 178
Research works printed but not linked: 1
- Bianchi, 1994, Pathology of the Liver, 349
Cited by
Items 101–200 of 277
Lee, H., Stapp, R., Ormsby, A., & Shah, V. V. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpe93gzshuntai · Cited by 30
Zen, Y., Harada, K., Sasaki, M., Tsuneyama, K., Matsui, K., Haratake, J., Sakisaka, S., Maeyama, S., Yamamoto, K., Nakano, M., et al. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-004-1514-7 · Cited by 31
Autoimmune Hepatitis Overlap Syndromes and Liver Pathology
Czaja, A. J., & Carpenter, H. A. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.01.008 · Cited by 34
“commonly as patients with classical AIH (81 vs 86%) and fail treatment as infrequently (14 vs 9%).(11,13,51,67,68) Treatment outcomes in patients with the overlap syndrome of AIH and PSC have been variable, possibly because of the severity or advanced nature of the PSC at”
Jeevagan, A. (2010) · International Journal of General Medicine · doi:10.2147/ijgm.s11201 · Cited by 30
“It is not clear whether these overlap syndromes form separate groups or are only variants of the major autoimmune hepatic diseases.(5) No standard diagnostic criteria for overlap syndromes has been achieved so far.”
RetractedHistological grading and staging in chronic hepatitis: Its practical correlation
Nakaji, M., Hayashi, Y., Ninomiya, T., Yano, Y., Yoon, S., Seo, Y., Nagano, H., Komori, H., Hashimoto, K., Orino, A., et al. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01410.x · Cited by 28
Variant syndromes of autoimmune hepatitis
Heathcote, J. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00031-4 · Cited by 29
“Lohse et al [34] described a group of patients with overlapping features of AIH and PBC and compared these ‘‘overlap’’ patients to others with either classic J.”
BackgroundResultHonda, M., Kawai, H. F., Shirota, Y., Yamashita, T., Takamura, T., & Kaneko, S. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.03.009 · Cited by 26
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
You, H., Duan, W., Li, S., Lv, T., Chen, S., Lu, L., Ma, X., Han, Y., Nan, Y., Xu, X., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00347 · Cited by 46
Toyoda, M., Yokomori, H., Kaneko, F., Yoshida, H., Hoshi, K., Takeuchi, H., Tahara, K., Takahashi, A., Kudo, T., Motoori, T., et al. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.2687 · Cited by 29
Enrique, C.-A., Julio, G., Misael, U., & Aldo, T. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31583-2 · Cited by 25
Kurihara, Y., Shishido, T., Oku, K., Takamatsu, M., Ishiguro, H., Suzuki, A., Sekita, T., Shinagawa, T., Ishihara, T., Nakashima, R., et al. (2011) · Modern Rheumatology · doi:10.1007/s10165-010-0397-0 · Cited by 25
Hepatobiliary associations with inflammatory bowel disease
Knight, C., & Murray, K. F. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.53 · Cited by 28
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
Lynch, J. P., Metz, D. C., Schuppan, D., Junker, Y., & Barisani, D. (2009) · Cited by 24
Gisbert, J. P., Jones, E. A., Pajares, J. M., & Moreno‐Otero, R. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01381.x · Cited by 28
Liu, F., Pan, Z. G., Ye, J., Xu, D., Guo, H., Li, G. P., Xu, K. S., Hou, X. H., & Song, Y. H. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12196 · Cited by 23
Bittencourt, P. L., Cançado, E. L. R., Couto, C. A., Levy, C., Porta, G., Silva, A. E. B., Terrabuio, D. R. B., de Carvalho‐Filho, R. J., CHAVES, D. M., Miura, I. K., et al. (2015) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032015000500002 · Cited by 24
“Small studies from the Netherlands (n=9) and Italy (n=7) have reported biochemical response in most of the patients treated with IS or UDCA+IS(187,188).”
ResultHLA-DR Polymorphism and Primary Biliary Cirrhosis: Evidence From a Meta-analysis
Li, M., Zheng, H., Tian, Q., Rui, M.-N., & Liu, D. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.03.002 · Cited by 26
Current topics in autoimmune hepatitis
Muratori, L., Muratori, P., Granito, A., Pappas, G., Cassani, F., & Lenzi, M. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.05.019 · Cited by 22
Autoimmune hepatitis in children
Squires, R. H. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0012-7 · Cited by 26
“The overlap syndromes are an enigmatic constellation of serologic and clinical symptoms that resemble both AIH and immune-mediated biliary tract disease, either primary biliary cirrhosis (AMA positive) [ 30 ] or sclerosing cholangitis (antineutrophilic cell antibody, perinuclear staining [pANCA] positive) [31,32].”
BackgroundOverlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases
Silveira, M. G., & Lindor, K. D. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.2.329 · Cited by 25
Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases
Dalekos, G. Ν., & Gatselis, N. (2019) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-019-00550-9 · Cited by 23
Autoimmune Hepatitis – Primary Biliary Cirrhosis Overlap Syndrome
Bairy, I., Berwal, A., & Seshadri, S. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/25193.10242 · Cited by 23
Recognizing autoimmune hepatitis: Scores help, but no more
Lohse, A. W. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.013 · Cited by 20
Self-citationHepatobiliar manifestations in inflammatory bowel disease: A practical approach
Paulina Núñez, F., Castro, F., Gabriel Mezzano, P., Quera, R., Díaz, D., & Castro, L. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i2.319 · Cited by 28
Variant Syndromes of Autoimmune Liver Diseases: Classification, Diagnosis and Management
Weiler‐Normann, C., & Lohse, A. W. (2016) · Digestive Diseases · doi:10.1159/000444472 · Cited by 21
Self-citationREVIEW: Overlap Syndromes of Autoimmune Hepatitis: What Is Known So Far
Durazzo, M., Premoli, A., Fagoonee, S., & Pellicano, R. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1022597210629 · Cited by 18
Immunopathogenesis of cholestatic autoimmune liver diseases
Medina, J., Jones, E. A., García‐Monzón, C., & Moreno‐Otero, R. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00765.x · Cited by 19
Primary Biliary Cirrhosis and Hepatitis C Virus Infection
Floreani, A., Baragiotta, A. M., Leone, M. G., Baldo, V., & Naccarato, R. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.021 · Cited by 18
“The overlap of AIH and PBC is very likely a form of PBC that develops a more hepatitis-like picture in genetically susceptible individuals”
BackgroundSato, Y., Harada, K., Sudo, Y., Watanabe, K., Nakahama, T., Morimoto, H., & Nakanuma, Y. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01377.x · Cited by 18
Autoimmune disease overlaps and the liver: Two for the price of one?
Mackay, I. R. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02041.x · Cited by 18
Post‐liver transplantation de novo hepatitis with overlap features
Keaveny, A. P., Gordon, F. D., & Khettry, U. (2005) · Pathology International · doi:10.1111/j.1440-1827.2005.01886.x · Cited by 18
Bogdanos, D. P., Liaskos, C., Rigopoulou, E. I., & Dalekos, G. Ν. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.04.001 · Cited by 18
Overlap syndrome of autoimmune chronic liver diseases: MRI findings
Hyslop, W. B., Kierans, A. S., Leonardou, P., Fritchie, K., Darling, J. M., El‐Azzazi, M., & Semelka, R. C. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22048 · Cited by 17
Korkmaz, H., Buğdacı, M. S., Temel, T., Dağlı, M., & Karabağli, P. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.11.001 · Cited by 17
Variant syndromes of primary biliary cholangitis
Schulz, L., Sebode, M., Weidemann, S. A., & Lohse, A. W. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.003 · Cited by 18
Self-citationNew insights into autoimmune liver diseases
Kumagi, T., Alswat, K., Hirschfield, G. M., & Heathcote, J. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00366.x · Cited by 18
Zen, Y., Hübscher, S. G., & Nakanuma, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00009-1 · Cited by 21
Alric, L., Thébault, S., Selves, J., Péron, J., Mejdoubi, S., Fortenfant, F., & Vinel, J. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89322-5 · Cited by 16
“For example, for some authors, autoimmune cholangitis is a subset of AMA-negative PBC [6, 10, 11] whereas the same term was used [4, 12, 13] to describe an independent entity overlapping between PBC and AIH.”
BackgroundResultInfluentialSakai, T., Arakawa, Y., Amaki, S., Miyakawa, H., Gotou, I., Tanaka, N., Moriyama, M., Iwasaki, A., Sugitani, M., & Arakawa, Y. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1322-5 · Cited by 17
Autoimmune Hepatitis: The Way We Were, the Way We Are Today and the Way We Hope to Be
Mackay, I. R., & Toh, B. (2002) · Autoimmunity · doi:10.1080/08916930290015610 · Cited by 16
“However, the “basic” disease among such overlap cases may well be PBC according to observations by Lohse et al.([46]) since their cases were essentially PBC, but occurring on an immunogenetic background (permissive HLA alleles, B8 and DR3) of autoimmune hepatitis.”
ResultZepeda-Gómez, S., Montaño‐Loza, A. J., Zapata-Colindres, J. C., Paz, F., Olivera-Martinez, M. A., López-Reyes, A. G., Granados, J., & Vargas‐Alarcón, G. (2009) · Immunological Investigations · doi:10.1080/08820130902846282 · Cited by 15
Graf, M., Lange, C. M., Langer, M., Schattenberg, J. M., Seeßle, J., Dietz, J., Vermehren, A., Michael, F. A., Mondorf, A. W., Zeuzem, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227047 · Cited by 20
“However, anti-SMAs are less specific for AIH and are also detected in up to 20% of PBC patients [25].”
BackgroundWobser, H., Paur, T., Schnoy, E., Hartl, J., & Kirchner, G. I. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617711632 · Cited by 15
Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease
Biecker, E., Stieger, M., Zimmermann, A., & Reichen, J. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200304000-00015 · Cited by 14
New autoantibodies and autoantigens in autoimmune hepatitis
Bianchi, F. B., Muratori, P., & Muratori, L. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00027-2 · Cited by 14
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect
Floreani, A., Gabbia, D., & Martin, S. D. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2242771 · Cited by 16
“The hypothesis of a variant form seems to be the most appropriate since PBC/AIH has been proposed as a ‘hepatitic’ form of PBC in genetically susceptible individuals (HLA-B8, DR3-, or DR4-positive) [38].”
BackgroundWeinmann, A., Sattler, T., Unold, H.-P., Grambihler, A., Teufel, A., Koch, S., Schuchmann, M., Biesterfeld, S., Wörns, M., Galle, P. R., et al. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000176 · Cited by 16
“Patient population Age at diagnosis (y) 52 (12-87) 55 (26-71) ( 7; 5) N.”
Abe, K., Takahashi, A., Nozawa, Y., Imaizumi, H., Hayashi, M., Okai, K., Kanno, Y., Watanabe, H., & Ohira, H. (2014) · Medical Molecular Morphology · doi:10.1007/s00795-014-0082-z · Cited by 14
“repeatedly reported [1, 15].”
Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan
Ohira, H., & Takahashi, A. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00904.x · Cited by 14
The Inconvenient Truth of Primary Biliary Cholangitis/Autoimmune Hepatitis Overlap Syndrome
Hussain, N., & Trivedi, P. J. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.007 · Cited by 16
Mawardi, M., Alalwan, A. M., Fallatah, H. I., Abaalkhail, F. A., Hasosah, M. Y., Shagrani, M. A., Alghamdi, M., & Alghamdi, A. (2021) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_112_21 · Cited by 14
“Patients may have a sequential development of overlap syndrome starting with PBC followed by the development of AIH.[120] Yet, patients may have a simultaneous presentation of both diseases.”
BackgroundSaito, H., Rai, T., Takahashi, A., Kanno, Y., Monoe, K., Irisawa, A., & Ohira, H. (2006) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.52.71 · Cited by 12
Kanda, T., Yokosuka, O., Hirasawa, Y., Imazeki, F., Nagao, K., & Saisho, H. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-3083-5 · Cited by 12
Büschenfelde, K. M. Z. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00408-7 · Cited by 12
WU, C.-H., WANG, Q.-H., TIAN, G.-S., XU, X.-Y., YU, Y.-Y., & WANG, G.-Q. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200602010-00013 · Cited by 12
Lazaridis, K. N., & Lindor, K. D. (1999) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-999-0051-0 · Cited by 12
Overlap Syndromes of Autoimmune Hepatitis: An Open Question
Durazzo, M., Premoli, A., Paschetta, E., Belci, P., Spandre, M., & Bo, S. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2378-y · Cited by 11
“in 1998 [9] are still widely accepted; they require the presence at least of two out of three specific criteria of each disorder: the PBC criteria include alkaline phosphatase (ALP) levels at least twice- or gamma-glutamyl transferase (cGT) levels at least five times the upper limit of normal, positive AMA, and a live…”
Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis
Schultheiß, C., Steinmann, S., Willscher, E., Paschold, L., Lohse, A. W., & Binder, M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000123 · Cited by 16
“It has been proposed that variant clinical/laboratory presentations may also result, if PBC is developed in an human leukocyte antigen (HLA) context predisposing to AIH, leading to the term PBC with secondary AIH.”
BackgroundInfluentialSelf-citationKayaçetin, E., Köklü, S., & Temuçin, T. K. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.09.023 · Cited by 12
“In most cases of AIH/PBC OS, clinical symptoms, biochemical parameters, and histopathology of both entities occur simultaneously [10,11].”
BackgroundCasas, O. Y. M., Díaz-Ramírez, G. S., Marín, J. I., Santos, O. M., Maya, O. G. M., Gómez, J. R. M., & Restrepo, J. C. (2018) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2018.05.019 · Cited by 14
Casas, O. Y. M., Díaz-Ramírez, G. S., Marín, J. I., Santos, O. M., Maya, O. G. M., Gómez, J. R. M., & Restrepo, J. C. (2018) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2018.11.006 · Cited by 16
Autoimmune hepatitis—is histology conclusive?
Beer, A., & Dienes, H. P. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5084 · Cited by 11
“Overlap syndrome of AIH and PBC (4,22-24): The diagnosis should be made only when the two concurrent diseases can be established and meet the criteria for each disease both clinically and histologically.”
BackgroundInfluentialSelf-citationPrimary biliary cirrhosis in classmates
von Mach, M.-A. (2002) · Technische Universität Dortmund Eldorado (Technische Universität Dortmund) · doi:10.17877/de290r-15144 · Cited by 12
Autoimmune Hepatitis: a Review of Established and Evolving Treatments
Bischoff, S., Yesmembetov, K., Antoni, C., Sollors, J., Evert, M., Ebert, M. P., & Teufel, A. (2020) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-2667 · Cited by 10
Diagnostik cholestatischer Erkrankungen
Geier, A., Gartung, C., Dietrich, C. G., Lammert, F., Wasmuth, H. E., & Matern, S. (2003) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-003-1294-5 · Cited by 13
Renou, C., Bourlière, M., Martini, F., Ouzan, D., Pénaranda, G., Larroque, O., Harafa, A., Igual, J., Calvet, B., Sokolowsky, S., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04252.x · Cited by 9
Cholestatic Liver Disease Overlap Syndromes
Mayo, M. J. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.006 · Cited by 9
Overlap syndromes: An emerging diagnostic and therapeutic challenge
Malhotra, S., & Dhiman, P. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.145316 · Cited by 8
Autoimmunerkrankungen der Leber
Pannicke, N., Schramm, C., & Lohse, A. W. (2012) · Der Internist · doi:10.1007/s00108-012-3096-4 · Cited by 7
Self-citationWatanabe, N., Takashimizu, S., Shiraishi, K., Kagawa, T., Nishizaki, Y., Mine, T., Akatsuka, A., Selmi, C. F., & Gershwin, M. E. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000230082.60921.be · Cited by 7
HEPATIC DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS: COINCIDENCE OR CONVERGENCE
MACKAY, I. (2004) · Elsevier eBooks · doi:10.1016/b9-78-012433-9/01950-0387 · Cited by 6
Ishibashi, H., Nakanuma, Y., Ueno, Y., Egawa, H., Koike, K., Komori, A., Sakisaka, S., Shimoda, S., Shirabe, K., Zeniya, M., et al. (2012) · Kanzo · doi:10.2957/kanzo.53.633 · Cited by 7
Ohba, K., Omagari, K., Kusakari, C., Kadokawa, Y., Hayashida, K., Takeshima, F., Mizuta, Y., Murata, I., Nakanuma, Y., & Kohno, S. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1301-1 · Cited by 6
“Usually, the overlap syndrome of PBC and AIH is a form of PBC that secondarily develops a more hepatitic nature either spontaneously or under UDCA therapy (5).”
BackgroundAutoimmunerkrankungen der Leber
Lüth, S., Weiler‐Normann, C., Schramm, C., & Lohse, A. W. (2009) · Der Internist · doi:10.1007/s00108-008-2254-1 · Cited by 6
Self-citationLohse, A. W., & Weiler‐Normann, C. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.032 · Cited by 6
Self-citationVallone, T. M., Ditelberg, J. S., & Kaplan, M. M. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1296-7 · Cited by 6
“, HLAB8, DR3, of DR4), tended to develop a more “hepatitic” form of PBC (4).”
BackgroundRapid-onset Primary Biliary Cirrhosis Resembling Drug-induced Liver Injury
Sohda, T., SHIGA, H., Nakane, H., Nishizawa, S., Yoshikane, M., Anan, A., Suzuki, N., Irie, M., Iwata, K., Watanabe, H., et al. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.1051 · Cited by 6
The variant forms of cholestatic diseases involving small bile ducts in adults
Chazouillères, O. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80437-7 · Cited by 6
Shibata, M., Morizane, T., Tanaka, A., Onozuka, Y., Uchida, T., Gershwin, M. E., & Mitamura, K. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02413.x · Cited by 6
PBC–AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management
Sebode, M., & Gerussi, A. (2025) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001149 · Cited by 5
The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants
Bolis, F., Cazzaniga, G., Pagni, F., Invernizzi, P., Carbone, M., & Gerussi, A. (2024) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastrohep.2024.502225 · Cited by 9
Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
Arulprakash, S., Sasi, A. D., Bala, M. R., Pugazhendhi, T., & Kumar, S., V (2010) · PubMed · Cited by 4
Yanagawa, T., Miyakawa, H., Shibata, M., Kawaguchi, N., Ishibashi, M., 後藤, 昇., & Mitamura, K. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00014-7 · Cited by 5
Minz, R. W., Chhabra, S., Aggarwal, R., Das, A., Saikia, B., & Chawla, Y. K. (2009) · Cases Journal · doi:10.1186/1757-1626-2-7491 · Cited by 5
“Taking the presence of DR3 in this patient, it is tempting to agree with Lohse's observation that a majority of patients with overlap syndrome have the characteristic HLA haplotype of AIH namely HLA-B8, DR3 or DR4 [8].”
ResultPrimary cholangiohepatitis as an alternative name for primary biliary cirrhosis
Nakanuma, Y., & Harada, K. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01490.x · Cited by 5
Goodman, Z. D. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch6 · Cited by 5
Hakem, D. J., BERRAH, A., Berkane, S., Asselah, H., Aït-Younes, S., Asselah, F., Salah, S., Merriche, S., & Abbadi, M. C. (2005) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2005.07.009 · Cited by 4
Umemura, M., Nagasaka, A., Fukasawa, Y., Fujita, Y., Endo, A., Nakamura, M., Nishikawa, S., & Higuchi, A. (2013) · Kanzo · doi:10.2957/kanzo.54.44 · Cited by 4
Chaouali, M., Kochkar, R., Messadi, A. A., Tezeghdenti, A., Azaiez, M. B., Abdallah, H. B., Yacoubi-Oueslati, B., & Ghazouani, E. (2017) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2017.02.003 · Cited by 5
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_4 · Cited by 3
Complete spectrum of AMA-M2 positive liver disease in north India
Minz, R. W., Kaur, N., Anand, S., Aggarwal, R., Saikia, B., Das, A., & Chawla, Y. K. (2011) · Hepatology International · doi:10.1007/s12072-011-9326-3 · Cited by 5
Ômori, K., Yoshida, K., Yokota, M., Daa, T., & Kan, M. (2016) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-016-0676-1 · Cited by 4
Dufour, D. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00050-0 · Cited by 6
MACKAY, I. R., Czaja, A. J., McFarlane, I. G., & Manns, M. P. (2006) · Elsevier eBooks · doi:10.1016/b978-012595961-2/50056-1 · Cited by 4
« Overlap syndrome » cirrhose biliaire primitive — hépatite auto-immune : le temps de la maturité ?
Chazouillères, O. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89321-3 · Cited by 6
“Pour les formes mixtes simultanées CBP-HAI, l’intérêt d’associer les corticoïdes à l’AUDC reste débattu dans la littérature [15, 16].”
Diagnostik der "seronegativen" chronischen Hepatitis am Gewebe
Drebber, U., Odenthal, M., Dries, V., Schirmacher, P., & Dienes, H. P. (2001) · Der Pathologe · doi:10.1007/s002920100485 · Cited by 4
Self-citationLi, M., Cao, W., Jiang, T., Deng, W., Wang, S., Wu, S., Zhang, L., Lu, Y., Chang, M., Liu, R., et al. (2024) · Biosafety and Health · doi:10.1016/j.bsheal.2024.04.004 · Cited by 4
“This combined therapy has resulted in high response rates in PBC patients with features of AIH, and these patients may bene fi t from such combined therapy [23 – 25].”
Prevalence and clinicopathological Spectrum of Auto-Immune Liver Diseases & Overlap syndrome
Varadarajan, A., Rastogi, A., Maiwall, R., Bihari, C., Thomas, S. S., Sood, V., & Shasthry, S. M. (2023) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_72_22 · Cited by 3
Overlap Syndromes with Autoimmune Hepatitis
Smith, A. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-118-5_5 · Cited by 3
“By contrast, Lohse et al selected 14 patients from a large number seen in their department over 20 years based on an increased ALT concentration or high titer of either ANA or SMA in conjunction with a positive AMA result ( 34 ).”
Background
Metadata
- Authors
- Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Cologne (DE)
- Corresponding author
- Lohse, Ansgar W.
- Venue
- Hepatology
- Published
- 1999-04
- Volume
- 29
- Issue
- 4
- Pages
- 1078-1084
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2171662843
- Semantic Scholar
- aede3440eeab4134d81165c39316c389536598b6
- Cited by
- 278
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 11 · 2016: 5 · 2015: 3 · 2014: 12 · 2013: 11 · 2012: 13
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5997 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft, Bonn ((SFB 311))
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, overlap syndrome, antimitochondrial antibodies, HLA-DR3, HLA-DR4, HLA-B8, genetic susceptibility, bile duct destruction, immunosuppressive therapy
- MeSH terms
- Adolescent, Adult, Aged, Autoantibodies, Biopsy, Female, Follow-Up Studies, Histocompatibility Testing, Humans, Immunosuppressive Agents, Liver Cirrhosis, Biliary, Male, Middle Aged, Serologic Tests, Syndrome, Hepatitis, Autoimmune, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.